Clinical Trial Update: A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase II clinical trial is evaluating Toripalimab with sequential neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Locally Advanced Esophageal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING